# Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908

**Authors:** Maria Anastasiou, Evangelos Oikonomou, Panagiotis Theofilis, Maria Gazouli, George-Angelos Papamikroulis, Athina Goliopoulou, Vasiliki Tsigkou, Vasiliki Skandami, Angeliki Margoni, Kyriaki Cholidou, Amanda Psyrri, Konstantinos Tsioufis, Flora Zagouri, Gerasimos Siasos, Dimitris Tousoulis

PMC · DOI: 10.3390/ph19020273 · Pharmaceuticals · 2026-02-06

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** Breast Cancer (MESH:D001943), injury to (MESH:D014947), Cardiotoxicity (MESH:D066126)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943342/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943342/full.md

---
Source: https://tomesphere.com/paper/PMC12943342